Home >> WEBINARS >> PD-L1 Testing in Metastatic Triple Negative Breast Cancer: Challenging Cases To Help Update Your Practice

PD-L1 Testing in Metastatic Triple Negative Breast Cancer: Challenging Cases To Help Update Your Practice

Print Friendly, PDF & Email

Tuesday, March 26, 2019, 1 PM–2 PM ET

Dr. Leisha A. Emens

Dr. Cimino-Mathews

Webinar presenters Ashley Cimino-Mathews, MD, Associate Professor of Pathology and Oncology Director of the Breast Pathology Program, The Johns Hopkins Hospital, Baltimore, Maryland, and Leisha A. Emens, MD, PhD, UPMC Hillman Cancer Center/Magee Women’s Hospital Director of Translational Immunotherapy for the Women’s Cancer Research Center, Co-Leader, Hillman Cancer Immunology/Immunotherapy Program, Pittsburgh, Pennsylvania, will discuss the challenges in PD-L1 testing in TNBC today.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Objectives:

  • Comprehend the challenges in PD-L1 testing in TNBC today
  • Gain insight into the optimal interchange between pathologists and oncologists
  • Understand the importance of PD-L1 testing in TNBC now and into the future
  • Ask your questions of our distinguished presenter
Register FREE of charge

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a promotional sponsorship from Genentech

X